Tatva Chintan Pharma Chem Ltd confirmed that there have been no deviations in the utilization of funds raised through its IPO, which totaled Rs. 2250 million, and reported that their Dahej Manufacturing Facility expansion has been completed at a revised cost of Rs. 1,529.35 million, funded by internal accruals.